Coherus Oncology

CHRS

Börsenwert 99 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
126	126 Farther Finance Advisors San Francisco, California	3.531 $	+629 $	+385	+18 %
127	127 CoreCap Advisors Southfield, Michigan	3.409 $	-60 $	-37	-1 %
128	128 Allworth Financial Folsom, California	3.066 $	+2.194 $	+1.344	+159 %
129	129 Sterling Capital Management Charlotte, North Carolina	2.611 $	-1.192 $	-730	-28 %
130	130 California State Teachers Retirement System (CalSTRS) West Sacramento, California	2.031 $	-7.002 $	-4.289	-75 %
131	131 Osaic Holdings Scottsdale, Arizona	1.451 $	-816 $	-500	-33 %
132	132 Steigerwald Gordon & Koch Leesburg, Virginia	1.400 $	–	–	–
133	133 GAMMA Investing Foster City, California	1.239 $	-531 $	-325	-27 %
134	134 Clearstead Advisors Cleveland, Ohio	1.170 $	+931 $	+570	+214 %
135	135 Essential Partners Rancho Santa Fe, California	1.124 $	-1.208 $	-740	-48 %
136	136 Owl Creek Wealth Partners Denver, Colorado	958 $	–	–	–
137	137 True Wealth Design Akron, Ohio	821 $	+402 $	+246	+72 %
138	138 Nisa Investment Advisors St. Louis, Missouri	804 $	–	–	–
139	139 IFP Advisors Tampa, Florida	734 $	-140 $	-86	-14 %
140	140 SJS Investment Consulting Sylvania, Ohio	703 $	+645 $	+395	+369 %
141	141 Rockefeller Capital Management New York	454 $	–	–	–
142	142 Rothschild Investment LLC Chicago, Illinois	286 $	+26 $	+16	+9 %
143	143 Cassaday & Co Wealth Management Mclean, Virginia	280 $	-294 $	-180	-47 %
144	144 Caitong International Asset Management Hong Kong	15 $	+18 $	+11	Neu
145	145 Huntington National Bank Columbus, Ohio	1 $	–	–	–
146	146 Tang Capital Management San Diego, California	–	-3,19 Mio. $	-1.886.748	Geschlossen
147	147 Propel Bio Management Los Angeles, California	–	-2,41 Mio. $	-1.420.550	Geschlossen
148	148 EAM Investors Solana Beach, California	–	-523.564 $	-309.801	Geschlossen
149	149 Marshall Wace London, United Kingdom	–	-456.447 $	-270.087	Geschlossen
150	150 Simplify Asset Management Las Vegas, Nevada	–	-427.807 $	-253.140	Geschlossen

Coherus Oncology CHRS Börsenwert 99 Mio. $

Coherus Oncology

CHRS

Börsenwert 99 Mio. $